You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Wild Type Rb Extensive Stage SCLC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston (drug,

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

SCLC,Extensive Stage Trial in Italy (Pembrolizumab/Olaparib)

Not yet recruiting
  • SCLC,Extensive Stage
  • Meldola, Forlì Cesena, Italy
  • +9 more
Nov 11, 2022

Reveal Patterns of Presentation, Management and Outcome of SCLC

Recruiting
  • Lung Cancer
    • Dammam, Saudi Arabia
    • +2 more
    Jul 25, 2022

    Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Durvalumab 50 MG/1 ML Intravenous Solution
    • +4 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Oct 31, 2022

    Outcomes ofBrazilian Cohort of Previously Untreated Extensive

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Observational study
    • (no location specified)
    Aug 24, 2023

    Extensive Stage Small Cell Lung Carcinoma Trial in United States (Pembrolizumab, Laboratory Biomarker Analysis)

    Active, not recruiting
    Has Results
    • Extensive Stage Small Cell Lung Carcinoma
    • Pembrolizumab
    • Laboratory Biomarker Analysis
    • Chicago, Illinois
    • +4 more
    Jun 28, 2022

    Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

    Recruiting
    • SCLC,Extensive Stage
    • PD-(L)1 antibody immunotherapy
    • Beijing, Beijing, China
      Peking University Cancer Hospital & Institute
    Jul 3, 2023

    Extensive-stage Small-cell Lung Cancer Trial in China (serplulimab, Cisplatin, Carboplatin)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Shantou, Guangdong, China
    • +6 more
    Mar 1, 2023

    Lung Cancer, Small Cell Trial in Hangzhou (Tislelizumab, Sitravatinib)

    Recruiting
    • Lung Cancer, Small Cell
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    May 13, 2022

    Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Cisplatin, Carboplatin)

    Active, not recruiting
    • Carcinoma, Small Cell Lung
    • Beijing City, China
    • +7 more
    Nov 24, 2022

    SCLC, Extensive Stage Trial in Shanghai (AK112, Etoposide, Carboplatin)

    Recruiting
    • SCLC, Extensive Stage
    • Shanghai, Shanghai, China
      Shun Lu
    Oct 12, 2022

    Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Jinan, China
    • +2 more
    Sep 10, 2023

    Safety of Zepzelca in Adult Extensive Stage Small Cell Lung

    Recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Huntsville, Alabama
    • +36 more
    Jul 25, 2022

    Small Cell Lung Carcinoma Trial in Italy (Atezolizumab, Carboplatin, Etoposide)

    Active, not recruiting
    • Small Cell Lung Carcinoma
    • Rionero In Vulture (PZ), Basilicata, Italy
    • +24 more
    Dec 12, 2022

    Extensive Stage Small Cell Lung Cancer Trial in France ([177Lu]Lu-DOTA-TATE, Tislelizumab, [68Ga]Ga-DOTA-TATE)

    Recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Lille, France
    • +6 more
    Jan 23, 2023

    Immunotherapy, Second-line Treatment Trial in Guizhou (Cadonilimab)

    Recruiting
    • Immunotherapy
    • Second-line Treatment
    • Guizhou, ZunYi, China
      The Second Affiliated Hospital of Zunyi Medical University
    Jun 14, 2023

    Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • quaratusugene ozeplasmid
    • atezolizumab
    • (no location specified)
    Jan 19, 2023

    Extensive-stage Small-cell Lung Cancer Trial (Surufatinib Durvalizumab EP/EC)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Surufatinib Durvalizumab EP/EC
    • (no location specified)
    Dec 20, 2022

    Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

    Not yet recruiting
    • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
    • (no location specified)
    Sep 19, 2023

    Small Cell Lung Cancer Trial in Cleveland (Alisertib)

    Not yet recruiting
    • Small Cell Lung Cancer
    • Cleveland, Ohio
      Cleveland Clinic
    Oct 18, 2023

    Small Cell Lung Carcinoma Extensive Disease Trial in China (Durvalumab plus chemo)

    Active, not recruiting
    • Small Cell Lung Carcinoma Extensive Disease
    • Durvalumab plus chemotherapy
    • Baoding, China
    • +29 more
    Nov 8, 2022

    Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab, MK-4830, MK-5890)

    Recruiting
    • Small Cell Lung Cancer
    • Pembrolizumab
    • +6 more
    • Gilbert, Arizona
    • +48 more
    Jan 19, 2023

    First-Line Serplulimab Plus Chemotherapy in Treatment of

    Not yet recruiting
    • Lung Cancer
    • Serplulimab plus chemotherapy
    • (no location specified)
    May 16, 2023

    Small Cell Lung Cancer Trial (SC0245, Irinotecan)

    Not yet recruiting
    • Small Cell Lung Cancer
    • (no location specified)
    Feb 7, 2023